Canyam
AI summaries for academic research
Home
Literature Help
Subscribe
Favorites
Tools
Analysis
Summary
Patents
Patent Payment
Patent Search
Not logged in
Back
Journal Details
Nature Reviews Drug Discovery
IF
101.8
Papers
5768
Citations
63436
Related Insights
0
subscribe
Journal Papers
5768
Related Insights
0
Journal Papers
5768
Publication Date
Publication Date
IF
Citations
First factor XIa inhibitor nabs FDA approval for stroke prevention
Nature Reviews Drug Discovery
IF
101.8
2026-11-11
0
PRE
AI
Asher Mullard
Share
Save
The expansion of kinase drug discovery: new targets, platforms and indications
Nature Reviews Drug Discovery
IF
101.8
2026-11-11
0
PRE
AI
Aleksandr V. Sokolov; Doriano Fabbro; Stefan Knapp; Helgi B. Schiöth
Share
Save
Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress
Nature Reviews Drug Discovery
IF
101.8
2026-11-09
0
PRE
AI
Bridget P. Keenan; Justin R. Killebrew; Diane Hollenbaugh; Lawrence Fong
Share
Save
Histone lysine demethylases in the third decade: biology and therapeutic prospects
Nature Reviews Drug Discovery
IF
101.8
2026-11-09
0
PRE
AI
Amir Hosseini; Yang Shi
Share
Save
Decision quality in biopharma portfolio renewal
Nature Reviews Drug Discovery
IF
101.8
2026-11-06
0
PRE
AI
Alberto Loche; Gaurav Agrawal; Jan Ascher
Share
Save
Regulatory lessons from FDA review of approved AAV gene therapies
Nature Reviews Drug Discovery
IF
101.8
2026-11-06
0
PRE
AI
Sojin Bing; Takele Argaw; Megha Kaushal; Ronit Mazor
Share
Save
Degraders take on GPCRs
Nature Reviews Drug Discovery
IF
101.8
2026-11-05
0
PRE
AI
Katie Kingwell
Share
Save
Linking kinase inhibitors for greater selectivity
Nature Reviews Drug Discovery
IF
101.8
2026-11-04
0
PRE
AI
M. Teresa Villanueva
Share
Save
FDA approves plasmid DNA-based immunotherapy for rare viral disease
Nature Reviews Drug Discovery
IF
101.8
2026-11-03
0
PRE
AI
Asher Mullard
Share
Save
Nanotherapy targets senescent cells
Nature Reviews Drug Discovery
IF
101.8
2026-10-26
0
PRE
AI
Sarah Crunkhorn
Share
Save
IL-21 mimic synergizes with KRAS inhibitors
Nature Reviews Drug Discovery
IF
101.8
2026-10-26
0
PRE
AI
Sarah Crunkhorn
Share
Save
Restoring antibiotic efficacy
Nature Reviews Drug Discovery
IF
101.8
2026-10-26
0
PRE
AI
Sarah Crunkhorn
Share
Save
In vivo engineered CAR NK cells
Nature Reviews Drug Discovery
IF
101.8
2026-10-26
0
PRE
AI
Sarah Crunkhorn
Share
Save
LNPs deliver large RNA cargos
Nature Reviews Drug Discovery
IF
101.8
2026-10-26
0
PRE
AI
Sarah Crunkhorn
Share
Save
Antagonizing adenosine receptors alleviates cardiac fibrosis
Nature Reviews Drug Discovery
IF
101.8
2026-10-26
0
PRE
AI
Sarah Crunkhorn
Share
Save
Bridging the capacity gap in advanced therapies
Nature Reviews Drug Discovery
IF
101.8
2026-10-26
0
PRE
AI
Anil Kumar Deshantri; Simone Punt; Ganesh Ramesh; Zsolt Sebestyen; Aurélie Mahalatchimy; Jorinde D. Hoogenboom; Jarl Mooyaart; Christian Chabannon; Jesús Fernández-Sojo; Manel Juan; Ulrike Koehl; Michael Hudecek; Carmen Sanges; Stephan Mielke; Chiara Bonini; Claire Roddie; Julio Delgado; Florent Malard; Simona Pagliuca; Annalisa Ruggeri; Trudy Straetemans; Jürgen Kuball
Share
Save
FDA approves hepatitis B antisense drug
Nature Reviews Drug Discovery
IF
101.8
2026-10-21
0
PRE
AI
Asher Mullard
Share
Save
Translating base editors: a decade of progress from the bench to the clinic
Nature Reviews Drug Discovery
IF
101.8
2026-10-16
0
PRE
AI
Nicole M. Gaudelli; Alexis C. Komor
Share
Save
One year of Commissioner’s National Priority Vouchers
Nature Reviews Drug Discovery
IF
101.8
2026-10-15
0
PRE
AI
Asher Mullard
Share
Save
FDA new drug approvals in Q3 2026
Nature Reviews Drug Discovery
IF
101.8
2026-10-14
0
PRE
AI
Paul Verdin
Share
Save
.png){kind=icon}
Not logged in.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}